147 results
8-K
EX-3.1
TNFA
TNF Pharmaceuticals Inc.
24 Jun 24
Material Modifications to Rights of Security Holders
4:23pm
for such purpose, or written consent without a meeting in accordance with the DGCL, of at least a majority of the outstanding Preferred Stock
8-K
EX-10.1
TNFA
TNF Pharmaceuticals Inc.
17 Jun 24
Entry into a Material Definitive Agreement
9:04am
of the Company’s common stock, par value $0.001 per share;
Whereas, the Investor holds at least a majority of the outstanding shares of Preferred Stock
8-K
EX-3.1
432tq0 qqtybdd2d
17 Jun 24
Entry into a Material Definitive Agreement
9:04am
8-K
EX-3.1
00fo4b5vsb9 3p
23 May 24
Material Modifications to Rights of Security Holders
4:05pm
8-K
EX-3.2
v0w1ockqn
23 May 24
Material Modifications to Rights of Security Holders
4:05pm
8-K
EX-3.2
oppwj88hkg69
21 May 24
MyMD Pharmaceuticals Secures Strategic Investments
9:10am
8-K
EX-3.1
ajirqe
21 May 24
MyMD Pharmaceuticals Secures Strategic Investments
9:10am
8-K
EX-4.1
sg7h6rl ps
21 May 24
MyMD Pharmaceuticals Secures Strategic Investments
9:10am
8-K
EX-10.2
as180qv4 2u
21 May 24
MyMD Pharmaceuticals Secures Strategic Investments
9:10am
8-K
EX-3.3
c5te2ao
21 May 24
MyMD Pharmaceuticals Secures Strategic Investments
9:10am
8-K
EX-4.2
13a5zl2n289qr4o8i
21 May 24
MyMD Pharmaceuticals Secures Strategic Investments
9:10am
8-K
EX-4.4
w7hca0qfbnkjogpa
21 May 24
MyMD Pharmaceuticals Secures Strategic Investments
9:10am
8-K
EX-10.1
6srizsodifapnpb0
21 May 24
MyMD Pharmaceuticals Secures Strategic Investments
9:10am
8-K
EX-4.3
55sttdru5ra
21 May 24
MyMD Pharmaceuticals Secures Strategic Investments
9:10am
8-K
EX-3.1
6v412e upkw
8 Apr 24
Entry into a Material Definitive Agreement
4:49pm
8-K
EX-10.1
1dzg 1y9t1iq
8 Apr 24
Entry into a Material Definitive Agreement
4:49pm